These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6612180)

  • 1. The effect of a local decongestant in acute rhinitis as related to body position.
    Geterud A; Rundcrantz H
    Rhinology; 1983 Jun; 21(2):155-8. PubMed ID: 6612180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal airflow asymmetry and the effects of a topical nasal decongestant.
    Williams RG; Eccles R
    Rhinology; 1992 Dec; 30(4):277-82. PubMed ID: 1281924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal decongestant therapy.
    Stride RD
    Br J Clin Pract; 1967 Nov; 21(11):541-8. PubMed ID: 4169455
    [No Abstract]   [Full Text] [Related]  

  • 4. Exploratory study of the decongestive effect of Rhinopront syrup in adults and in children with acute rhinitis.
    Lebacq E; Gline JP; Joue P; Stockis A; Calderon P; Van Schoor O; Deroubaix X; Schwegler F
    Clin Trials Metaanal; 1994 Oct; 29(2-3):113-24. PubMed ID: 10151073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigation of the effect of oxymetazoline on the duration of rhinitis. results of a placebo-controlled double-blind study in patients with acute rhinitis].
    Reinecke S; Tschaikin M
    MMW Fortschr Med; 2005 Oct; 147 Suppl 3():113-8. PubMed ID: 16261947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Investigation of the effect of oxymetazoline on the duration of rhinitis].
    Reinecke S; Tschaikin M
    MMW Fortschr Med; 2005 Oct; 147(41):46. PubMed ID: 16270513
    [No Abstract]   [Full Text] [Related]  

  • 7. A study of the effect of nasal steroid sprays in perennial allergic rhinitis patients with rhinitis medicamentosa.
    Ferguson BJ; Paramaesvaran S; Rubinstein E
    Otolaryngol Head Neck Surg; 2001 Sep; 125(3):253-60. PubMed ID: 11555762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A trial of Iliadin in non-specific allergic rhinitis.
    Leitch GB
    Br J Clin Pract; 1976 Feb; 30(2):37-42. PubMed ID: 56185
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical test of oxymetazoline-HCl-nose drops for infants (Nasivin 0,01 per cent)].
    Rüggeberg F
    Z Allgemeinmed; 1974 Apr; 50(11):535-7. PubMed ID: 4135074
    [No Abstract]   [Full Text] [Related]  

  • 10. Investigation of Cytotoxic Effects of Oxymetazoline on Lungs in a Rat Model of Rhinitis Medicamentosa.
    Cengiz B; Bostancıklıoğlu M; Demir T; Karabulut H; Dokuyucu R; Ulaşlı M
    Curr Mol Pharmacol; 2021 Oct; 14(4):658-666. PubMed ID: 32718303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a new oxymetazoline preparation in the treatment of nasal congestion. A multicentre trial.
    Practitioner; 1975 May; 214(1283):685-688. PubMed ID: 49890
    [No Abstract]   [Full Text] [Related]  

  • 12. Nasal airway resistance in perennial non-allergic rhinitis. Postural variations and effects of topical application of terbutaline.
    Broms P; Malm L; Svensson G
    Rhinology; 1982 Jun; 20(2):73-9. PubMed ID: 7111988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular effects of topical oxymetazoline on human nasal mucosa.
    Bende M; Löth S
    J Laryngol Otol; 1986 Mar; 100(3):285-8. PubMed ID: 3950497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of topical decongestant on blood flow in normal and infected nasal mucosa.
    Bende M
    Acta Otolaryngol; 1983; 96(5-6):523-7. PubMed ID: 6637461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the nasal decongestant oxymetazoline on human olfactory and intranasal trigeminal function in acute rhinitis.
    Hummel T; Rothbauer C; Pauli E; Kobal G
    Eur J Clin Pharmacol; 1998 Sep; 54(7):521-8. PubMed ID: 9832293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis.
    Watanabe H; Foo TH; Djazaeri B; Duncombe P; Mackay IS; Durham SR
    Rhinology; 2003 Sep; 41(3):167-74. PubMed ID: 14579657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decongestant activity of a new formulation of xylometazoline nasal spray: a double-blind, randomized versus placebo and reference drugs controlled, dose-effect study.
    Castellano F; Mautone G
    Drugs Exp Clin Res; 2002; 28(1):27-35. PubMed ID: 12073765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reciprocal changes in nasal resistance in response to changes in posture.
    Babatola FD
    Rhinology; 1998 Jun; 36(2):69-72. PubMed ID: 9695161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiologic and clinical estimates of the relief of nasal flow obstruction in allergic rhinitis: effects of a topical decongestant (oxymetazoline).
    Cohen BM; Duffy EP
    J Asthma Res; 1969 Dec; 7(2):65-73. PubMed ID: 4189976
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of a new administration form of oxymetazoline on maxillary ostial patency in healthy individuals and patients with acute rhinitis.
    Ackerhans M; Jannert M; Tönnesson M
    Acta Otolaryngol Suppl; 1994; 515():49-52. PubMed ID: 8067244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.